Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Identifying site- and stimulation-specific TMS-evoked EEG potentials using a quantitative cosine similarity metric.

Freedberg M, Reeves JA, Hussain SJ, Zaghloul KA, Wassermann EM.

PLoS One. 2020 Jan 13;15(1):e0216185. doi: 10.1371/journal.pone.0216185. eCollection 2020.

2.

Optimizing Hippocampal-Cortical Network Modulation via Repetitive Transcranial Magnetic Stimulation: A Dose-Finding Study Using the Continual Reassessment Method.

Freedberg M, Reeves JA, Toader AC, Hermiller MS, Kim E, Haubenberger D, Cheung YK, Voss JL, Wassermann EM.

Neuromodulation. 2019 Oct 30. doi: 10.1111/ner.13052. [Epub ahead of print]

PMID:
31667947
3.

Persistent Enhancement of Hippocampal Network Connectivity by Parietal rTMS Is Reproducible.

Freedberg M, Reeves JA, Toader AC, Hermiller MS, Voss JL, Wassermann EM.

eNeuro. 2019 Oct 16;6(5). pii: ENEURO.0129-19.2019. doi: 10.1523/ENEURO.0129-19.2019. Print 2019 Sep/Oct.

4.

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy.

Yalniz FF, Berdeja JG, Maris MB, Lyons RM, Reeves JA Jr, Essell JH, Patel P, Sekeres M, Hughes A, Mappa S, Garcia-Manero G.

Br J Haematol. 2020 Feb;188(3):404-412. doi: 10.1111/bjh.16173. Epub 2019 Aug 29.

PMID:
31468521
5.

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).

Hurwitz HI, Tan BR, Reeves JA, Xiong H, Somer B, Lenz HJ, Hochster HS, Scappaticci F, Palma JF, Price R, Lee JJ, Nicholas A, Sommer N, Bendell J.

Oncologist. 2019 Jul;24(7):921-932. doi: 10.1634/theoncologist.2018-0344. Epub 2018 Dec 14.

6.

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T.

Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0235-z.

PMID:
30291359
7.

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T.

Nat Med. 2018 Jun;24(6):749-757. doi: 10.1038/s41591-018-0053-3. Epub 2018 Jun 4. Erratum in: Nat Med. 2018 Dec;24(12):1941.

8.

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S.

J Clin Oncol. 2017 Nov 1;35(31):3538-3546. doi: 10.1200/JCO.2017.73.2784. Epub 2017 Sep 1.

PMID:
28862883
9.

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.

Berdeja JG, Bauer T, Arrowsmith E, Essell J, Murphy P, Reeves JA Jr, Boccia RV, Donnellan W, Flinn I.

Br J Haematol. 2017 Apr;177(2):254-262. doi: 10.1111/bjh.14536. Epub 2017 Feb 7.

PMID:
28169430
10.

Factor VII deficiency diagnosed after minor genital trauma.

Reeves JA, Dowlut-McElroy T, Mou SM, Strickland JL, Carpenter SL.

Haemophilia. 2017 Mar;23(2):e133-e135. doi: 10.1111/hae.12979. Epub 2017 Jan 22. No abstract available.

PMID:
28111834
11.

Rise and Fall: Poly(phenyl vinyl ketone) Photopolymerization and Photodegradation under Visible and UV Radiation.

Reeves JA, Allegrezza ML, Konkolewicz D.

Macromol Rapid Commun. 2017 Jul;38(13). doi: 10.1002/marc.201600623. Epub 2017 Jan 3.

PMID:
28044387
12.

A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma.

Pal SK, Drabkin HA, Reeves JA, Hainsworth JD, Hazel SE, Paggiarino DA, Wojciak J, Woodnutt G, Bhatt RS.

Cancer. 2017 Feb 15;123(4):576-582. doi: 10.1002/cncr.30393. Epub 2016 Oct 11.

13.

A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).

Hainsworth JD, Reeves JA, Mace JR, Crane EJ, Hamid O, Stille JR, Flynt A, Roberson S, Polzer J, Arrowsmith ER.

Target Oncol. 2016 Oct;11(5):643-653.

PMID:
27154357
14.

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films.

Hald ES, Steucke KE, Reeves JA, Win Z, Alford PW.

J Vis Exp. 2015 Jun 26;(100):e52971. doi: 10.3791/52971.

15.

Long-term vascular contractility assay using genipin-modified muscular thin films.

Hald ES, Steucke KE, Reeves JA, Win Z, Alford PW.

Biofabrication. 2014 Sep 23;6(4):045005. doi: 10.1088/1758-5082/6/4/045005.

PMID:
25245868
16.

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF.

Blood. 2008 Jan 1;111(1):86-93. Epub 2007 Sep 24.

PMID:
17893227
17.

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH.

J Clin Oncol. 2004 Mar 1;22(5):785-94.

PMID:
14990633
18.

Small-cell lung carcinoma: an analysis of 194 consecutive patients.

Dosoretz DE, Rubenstein JH, Katin MJ, Blitzer PH, Reisinger SA, Garton GR, Salenius SA, Harwin WH, Teufel TE, Raymond MG, Reeves JA, Rubin MS, Hart LL, McCleod MJ, Pizarro A, Gabarda AL.

Am J Clin Oncol. 1998 Aug;21(4):333-7.

PMID:
9708628
19.

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.

Grote TH, Pineda LF, Figlin RA, Pendergrass KB, Hesketh PJ, Karlan BY, Reeves JA, Porter LL, Benedict CR, Hahne WF.

Cancer J Sci Am. 1997 Jan-Feb;3(1):45-51.

PMID:
9072308
20.

Black widow spider bite in a child.

Reeves JA, Allison EJ Jr, Goodman PE.

Am J Emerg Med. 1996 Sep;14(5):469-71. Review.

PMID:
8765113
21.

Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung.

Rubenstein JH, Dosoretz DE, Katin MJ, Blitzer PH, Salenius SA, Floody PA, Harwin WN, Teufel TE, Raymond MG, Reeves JA, et al.

Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):329-37.

PMID:
7673020
22.
23.

Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal cells.

Kraft AS, Reeves JA, Ashendel CL.

J Biol Chem. 1988 Jun 15;263(17):8437-42.

24.

Metabolic and endocrine alterations induced by endotoxin and sepsis at the cellular level.

Spitzer JA, Leach GJ, Reeves JA.

Prog Clin Biol Res. 1981;62:123-30. No abstract available.

PMID:
7025009
25.

Pheochromocytoma with renal artery compression in an identical twin.

Kerzner MS, Reeves JA, DeNyse D, Claunch BC.

Arch Intern Med. 1968 Jan;121(1):91-4. No abstract available.

PMID:
5635077
26.

KERATOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

REEVES JA.

Arch Ophthalmol. 1965 Aug;74:159-60. No abstract available.

PMID:
14318487

Supplemental Content

Loading ...
Support Center